Biomarkers of immune activation to screen for severe, acute GVHD

被引：35

作者：

August, K. J. ^{[1
,2
,3
]}

Chiang, K-Y ^{[1
,2
,3
]}

Bostick, R. M. ^{[4
,5
]}

Flanders, W. D. ^{[4
]}

Waller, E. K. ^{[5
]}

Langston, A. ^{[5
]}

Worthington-White, D. ^{[1
,2
,3
]}

Rowland, P. ^{[1
,2
,3
]}

Moore, K. F. ^{[1
,2
,3
]}

Khoury, H. J. ^{[5
]}

Horan, J. T. ^{[1
,2
,3
]}

机构：

[1] Emory Univ, Aflac Canc Ctr, Atlanta, GA 30322 USA

[2] Emory Univ, Blood Disorders Serv, Atlanta, GA 30322 USA

[3] Childrens Healthcare Atlanta, Atlanta, GA USA

[4] Emory Univ, Dept Epidemiol, Rollins Sch Publ Hlth, Atlanta, GA 30322 USA

[5] Emory Univ, Sch Med, Winship Canc Inst, Atlanta, GA USA

来源：

BONE MARROW TRANSPLANTATION | 2011年 / 46卷 / 04期

关键词：

BONE-MARROW-TRANSPLANTATION; SYSTEMIC-LUPUS-ERYTHEMATOSUS; VERSUS-HOST-DISEASE; SOLUBLE INTERLEUKIN-2-RECEPTOR; SERUM-LEVELS; GRAFT; CALPROTECTIN; MARKER;

D O I：

10.1038/bmt.2010.165

中图分类号：

Q6 [生物物理学];

学科分类号：

071011 ;

摘要：

[No abstract available]

引用

页码：601 / 604

页数：4

共 19 条

[1] Cytomegalovirus pp65 antigenemia-guided early treatment with ganciclovir versus ganciclovir at engraftment after allogeneic marrow transplantation: A randomized double-blind study [J].

Boeckh, M ;

Gooley, TA ;

Myerson, D ;

Cunningham, T ;

Schoch, G ;

Bowden, RA .

BLOOD, 1996, 88 (10) :4063-4071

[2] Change in plasma tumor necrosis factor receptor 1 levels in the first week after myeloablative allogeneic transplantation correlates with severity and incidence of GVHD and survival [J].

Choi, Sung W. ;

Kitko, Carrie L. ;

Braun, Thomas ;

Paczesny, Sophie ;

Yanik, Gregory ;

Mineishi, Shin ;

Krijanovski, Oleg ;

Jones, Dawn ;

Whitfield, Joel ;

Cooke, Kenneth ;

Hutchinson, Raymond J. ;

Ferrara, James L. M. ;

Levine, John E. .

BLOOD, 2008, 112 (04) :1539-1542

[3] Calprotectin is a stronger predictive marker of relapse in ulcerative colitis than in Crohn's disease [J].

Costa, F ;

Mumolo, MG ;

Ceccarelli, L ;

Bellini, M ;

Romano, MR ;

Sterpi, C ;

Ricchiuti, A ;

Marchi, S ;

Bottai, M .

GUT, 2005, 54 (03) :364-368

[4]

EINSELE H, 1995, BLOOD, V86, P2815

[5] CLINICAL MANIFESTATIONS OF GRAFT VERSUS HOST DISEASE IN HUMAN RECIPIENTS OF MARROW FROM HL-A-MATCHED SIBLING DONORS [J].

GLUCKSBERG, H ;

STORB, R ;

FEFER, A ;

BUCKNER, CD ;

NEIMAN, PE ;

CLIFT, RA ;

LERNER, KG ;

THOMAS, ED .

TRANSPLANTATION, 1974, 18 (04) :295-304

[6] Soluble interleukin-2 receptor serum levels after allogeneic bone marrow transplantation as a marker for GVHD [J].

Grimm, J ;

Zeller, W ;

Zander, AR .

BONE MARROW TRANSPLANTATION, 1998, 21 (01) :29-32

[7] Detection of circulating soluble CD28 in patients with systemic lupus erythematosus, primary Sjogren's syndrome and systemic sclerosis [J].

Hebbar, M ;

Jeannin, P ;

Magistrelli, G ;

Hatron, PY ;

Hachulla, E ;

Devulder, B ;

Bonnefoy, JY ;

Delneste, Y .

CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2004, 136 (02) :388-392

[8] The soluble CD40 ligand sCD154 in systemic lupus erythematosus [J].

Kato, K ;

Santana-Sahagún, E ;

Rassenti, LZ ;

Weisman, MH ;

Tamura, N ;

Kobayashi, S ;

Hashimoto, H ;

Kipps, TJ .

JOURNAL OF CLINICAL INVESTIGATION, 1999, 104 (07) :947-955

[9] Noninvasive markers in the assessment of intestinal inflammation in inflammatory bowel diseases: Performance of fecal lactoferrin, calprotectin, and PMN-Elastase, CRP, and clinical indices [J].

Langhorst, Jost ;

Elsenbruch, Sigrid ;

Koelzer, Julia ;

Rueffer, Andreas ;

Michalsen, Andreas ;

Dobos, Gustav J. .

AMERICAN JOURNAL OF GASTROENTEROLOGY, 2008, 103 (01) :162-169

[10]

LINKERISRAELI M, 1994, J IMMUNOL, V152, P3158

← 1 2 →